🟢 WuXi Biologics is trading 4.11% up today amid broad Hong Kong biotech gains

WuXi Biologics is trading 4.11% up at HK$55.70, amid a broad Hong Kong biopharmaceutical stock rally; no WuXi-specific catalyst was identified for September 30.

• A September 30 market report said CanSino Biologics rose over 19%, Laekna-B more than 18%, and GenScript Biotech nearly 9%.
• WuXi Biologics closed at HK$53.50 on September 29. Trading volume was not provided, and the precise cause of the sector rally remains unclear.